- Filed
- May 6, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Apr 28, 2022 | 87.86M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2022 | 87.46M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2021 | 85.44M sh |
| Capex | Q1 2022 · Mar 31, 2022 | $2.15M |
| Capex | Q1 2022 · Mar 31, 2021 | $1.37M |
| Operating Cash Flow | Q1 2022 · Mar 31, 2022 | −$23.07M |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | −$28.25M |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $1.48B |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $1.51B |
| Cash And Equivalents | Q1 2022 · Mar 31, 2021 | $638.79M |
| Stockholders Equity | Q1 2022 · Mar 31, 2022 | $1.04B |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | $1.03B |
| Stockholders Equity | Q1 2022 · Mar 31, 2021 | $1.08B |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | $1.08B |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $558.1M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $567.67M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $1.64B |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $1.67B |
| Current Assets | Q1 2022 · Mar 31, 2022 | $1.76B |
| Current Assets | Q1 2022 · Dec 31, 2021 | $1.78B |
| Total Assets | Q1 2022 · Mar 31, 2022 | $2.67B |
| Total Assets | Q1 2022 · Dec 31, 2021 | $2.7B |
| Sga Expense | Q1 2022 · Mar 31, 2022 | $42.19M |
| Sga Expense restated | Q1 2022 · Mar 31, 2021 | $31.2M |
| Rd Expense | Q1 2022 · Mar 31, 2022 | $50.85M |
| Rd Expense restated | Q1 2022 · Mar 31, 2021 | $39.27M |
| Net Income | Q1 2022 · Mar 31, 2022 | −$32.56M |
| Net Income restated | Q1 2022 · Mar 31, 2021 | −$30.07M |
| Operating Income | Q1 2022 · Mar 31, 2022 | −$35.09M |
| Operating Income restated | Q1 2022 · Mar 31, 2021 | −$25.46M |
| Gross Profit | Q1 2022 · Mar 31, 2022 | $144.4M |
| Gross Profit restated | Q1 2022 · Mar 31, 2021 | $109.11M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2022 | $60.13M |
| Cost Of Revenue restated | Q1 2022 · Mar 31, 2021 | $44.5M |
| Revenue | Q1 2022 · Mar 31, 2022 | $204.53M |
| Revenue | Q1 2022 · Mar 31, 2021 | $153.6M |